Top

Published in:

01-06-2007 | Bone and Soft Tissue Sarcomas

Treatment and Outcome of 82 Patients with Angiosarcoma

Authors: John A. Abraham, MD, Francis J. Hornicek, MD, PhD, Adam M. Kaufman, BS, David C. Harmon, MD, Dempsey S. Springfield, MD, Kevin A. Raskin, MD, Henry J. Mankin, MD, David G. Kirsch, MD, PhD, Andrew E. Rosenberg, MD, G. Petur Nielsen, MD, Vikram Desphpande, MD, Herman D. Suit, MD, MSc, PhD, Thomas F. DeLaney, MD, Sam S. Yoon, MD

Published in: Annals of Surgical Oncology | Issue 6/2007

Abstract

Background

Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites.

Methods

Patients with a diagnosis of angiosarcoma treated at our institution between 1980 and 2006 were analyzed for patient demographics, tumor characteristics, multimodality treatment, and outcomes.

Results

A total of 82 patients were divided into those with primary and advanced disease. Overall, the median age was 65 (range, 22–91) years, and 44% of patients were women. Median size of tumors was 3.8 cm, and 76% of tumors were intermediate or high grade. Tumors were located throughout the body: 32 cutaneous, 22 deep soft tissues or organs, 10 radiation or lymphedema field, 8 bone, and 7 nonirradiated breast. Of 46 patients with primary disease, all patients underwent surgical resection, 67% received radiotherapy, and 27% received chemotherapy. Five-year disease-specific survival was 60%, and negative prognostic factors included intermediate or high grade, and tumors arising in a radiated or lymphedema field. Of 36 patients with advanced disease, 36% underwent a palliative operation, 78% received radiation, and 58% received chemotherapy. Median survival was just 7.3 months, and cutaneous tumors predicted a better prognosis compared with other sites.

Conclusions

Primary angiosarcomas treated with aggressive surgical resection and the addition of radiation for close margins or worrisome pathologic features can result in long-term survival in most patients. The role of adjuvant chemotherapy is unclear. Patients with advanced disease have a poor prognosis, but there can be dramatic responses to chemotherapy in a minority of patients.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106–30PubMedCrossRef

Brennan MF, Lewis JL. Diagnosis and Management of Soft Tissue Sarcoma. London: Martin Dunitz; 2002

Weiss SW, Goldblum JR. Enzingers and Weiss’s Soft Tissue Tumors. St. Louis: Mosby; 2001

Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg 2004; 239:903–9PubMedCrossRef

Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. Cancer 1949; 1:64CrossRef

Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996; 77:2400–6PubMedCrossRef

Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 22:683–97PubMedCrossRef

Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 457–81

Cox D. Regression models and life-tables. J R Stat Soc 1972; 34:187–220

10.

Pawlik TM, Paulino AF, McGinn CJ, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003; 98:1716–26PubMedCrossRef

11.

Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14:1679–89PubMed

12.

Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 2005; 11:241–7PubMedCrossRef

13.

Robinson E, Neugut AI, Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988; 80:233–40PubMedCrossRef

14.

Monroe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer 2003; 97:1832–40PubMedCrossRef

15.

Stewart FW, Treves N. Classics in oncology: lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. CA Cancer J Clin 1981; 31:284–99PubMed

16.

Muller R, Hajdu SI, Brennan MF. Lymphangiosarcoma associated with chronic filarial lymphedema. Cancer 1987; 59:179–83PubMedCrossRef

17.

Wehrli BM, Janzen DL, Shokeir O, Masri BA, Byrne SK, O’Connell JX. Epithelioid angiosarcoma arising in a surgically constructed arteriovenous fistula: a rare complication of chronic immunosuppression in the setting of renal transplantation. Am J Surg Pathol 1998; 22:1154–9PubMedCrossRef

18.

Jennings TA, Peterson L, Axiotis CA, Friedlaender GE, Cooke RA, Rosai J. Angiosarcoma associated with foreign body material. A report of three cases. Cancer 1988; 62:2436–44PubMedCrossRef

19.

Weiss SW, Goldblum JR. Malignant vascular tumors. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss’s Soft Tissue Tumors. St. Louis: Mosby, 2001:917–54

20.

Popper H, Thomas LB, Telles NC, Falk H, Selikoff IJ. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol 1978; 92:349–69PubMed

21.

Lee FI, Smith PM, Bennett B, Williams DM. Occupationally related angiosarcoma of the liver in the United Kingdom 1972–1994. Gut 1996; 39:312–8PubMed

22.

Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp: prognosis and treatment. Cancer 1987; 59:1046–57PubMedCrossRef

23.

Janigan DT, Husain A, Robinson NA. Cardiac angiosarcomas. A review and a case report. Cancer 1986; 57:852–9PubMedCrossRef

24.

Neshiwat LF, Friedland ML, Schorr-Lesnick B, Feldman S, Glucksman WJ, Russo RD Jr. Hepatic angiosarcoma. Am J Med 1992; 93:219–22PubMedCrossRef

25.

Neuhauser TS, Derringer GA, Thompson LD, Fanburg-Smith JC, Miettinen M, Saaristo A, Abbondanzo SL. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod Pathol 2000; 13:978–87PubMedCrossRef

26.

Kruger S, Kujath P, Johannisson R, Feller AC. Primary epithelioid angiosarcoma of the adrenal gland case report and review of the literature. Tumori 2001; 87:262–5PubMed

27.

Butany J, Yu W. Cardiac angiosarcoma: two cases and a review of the literature. Can J Cardiol 2000; 16:197–205PubMed

28.

Roy P, Clark MA, Thomas JM. Stewart-Treves syndrome—treatment and outcome in six patients from a single centre. Eur J Surg Oncol 2004; 30:982–6PubMedCrossRef

29.

Evans HL, Raymond AK, Ayala AG. Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol 2003; 34:680–9PubMedCrossRef

30.

Deshpande V, Rosenberg AE, O’Connell JX, Nielsen GP. Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol 2003; 27:709–16PubMedCrossRef

31.

Wenger DE, Wold LE. Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 2000; 29:619–31PubMedCrossRef

32.

Wold LE, Unni KK, Beabout JW, Ivins JC, Bruckman JE, Dahlin DC. Hemangioendothelial sarcoma of bone. Am J Surg Pathol 1982; 6:59–70PubMedCrossRef

33.

Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer 2004; 91:237–41PubMed

34.

Zelek L, Llombart-Cussac A, Terrier P, et al. Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol 2003; 21:2583–8PubMedCrossRef

35.

Gutman H, Pollock RE, Ross MI, et al. Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery 1994; 116:505–9PubMed

36.

Delaney TF, Trofimov AV, Engelsman M, Suit HD. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control 2005; 12:27–35PubMed

37.

Fata F, O’Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86:2034–7PubMedCrossRef

38.

Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005; 104:361–6PubMedCrossRef

Title: Treatment and Outcome of 82 Patients with Angiosarcoma
Authors: John A. Abraham, MD
Francis J. Hornicek, MD, PhD
Adam M. Kaufman, BS
David C. Harmon, MD
Dempsey S. Springfield, MD
Kevin A. Raskin, MD
Henry J. Mankin, MD
David G. Kirsch, MD, PhD
Andrew E. Rosenberg, MD
G. Petur Nielsen, MD
Vikram Desphpande, MD
Herman D. Suit, MD, MSc, PhD
Thomas F. DeLaney, MD
Sam S. Yoon, MD
Publication date: 01-06-2007
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 6/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-006-9335-y

At a glance: The STEP trials

Springer Medicine

Treatment and Outcome of 82 Patients with Angiosarcoma

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2007

Lymphedema Therapy Reduces the Volume of Edema and Pain in Patients with Breast Cancer

Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma

Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines

Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease—Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004

Factors Influencing the Volume-Outcome Relationship in Gastrectomies: A Population-Based Study

High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies